Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 872

1.

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators.

J Am Coll Cardiol. 2009 Jul 21;54(4):312-21. doi: 10.1016/j.jacc.2009.03.055.

2.

Use of a continuous-flow device in patients awaiting heart transplantation.

Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators.

N Engl J Med. 2007 Aug 30;357(9):885-96.

3.

Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS; HeartMate II Investigators.

J Am Coll Cardiol. 2010 Apr 27;55(17):1826-34. doi: 10.1016/j.jacc.2009.12.052.

4.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

5.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
6.

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.

Circulation. 1994 Nov;90(5 Pt 2):II83-6.

PMID:
7955290
7.

HeartMate left ventricular assist device as bridge to heart transplantation.

Koul B, Solem JO, Steen S, Casimir-Ahn H, Granfeldt H, Lönn UJ.

Ann Thorac Surg. 1998 Jun;65(6):1625-30.

PMID:
9647070
8.

End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.

Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH.

J Heart Lung Transplant. 2007 Aug;26(8):815-8. Epub 2007 Jul 6.

PMID:
17692785
9.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.

10.

Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD.

J Am Coll Cardiol. 2011 May 10;57(19):1890-8. doi: 10.1016/j.jacc.2010.10.062. Erratum in: J Am Coll Cardiol. 2011 Nov 8;58(20):2142.

11.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

12.

Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.

Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN 3rd; INTrEPID Investigators.

J Am Coll Cardiol. 2007 Aug 21;50(8):741-7. Epub 2007 Aug 6.

13.

Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?

Klotz S, Stypmann J, Welp H, Schmid C, Drees G, Rukosujew A, Scheld HH.

Ann Thorac Surg. 2006 Nov;82(5):1774-8.

PMID:
17062246
14.

Advanced heart failure treated with continuous-flow left ventricular assist device.

Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators.

N Engl J Med. 2009 Dec 3;361(23):2241-51. doi: 10.1056/NEJMoa0909938. Epub 2009 Nov 17.

15.

Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation.

Bogaev RC, Pamboukian SV, Moore SA, Chen L, John R, Boyle AJ, Sundareswaran KS, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators.

J Heart Lung Transplant. 2011 May;30(5):515-22. doi: 10.1016/j.healun.2010.12.009. Epub 2011 Jan 22.

PMID:
21257321
16.

Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.

Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R.

J Heart Lung Transplant. 2009 Apr;28(4):352-9. doi: 10.1016/j.healun.2009.01.005.

PMID:
19332262
17.

Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.

Garcia S, Kandar F, Boyle A, Colvin-Adams M, Lliao K, Joyce L, John R.

J Heart Lung Transplant. 2008 Mar;27(3):261-7. doi: 10.1016/j.healun.2007.12.001.

PMID:
18342746
18.

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators.

J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24. doi: 10.1016/j.jtcvs.2009.11.020. Epub 2010 Feb 4.

19.

Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.

Petrucci RJ, Rogers JG, Blue L, Gallagher C, Russell SD, Dordunoo D, Jaski BE, Chillcott S, Sun B, Yanssens TL, Tatooles A, Koundakjian L, Farrar DJ, Slaughter MS.

J Heart Lung Transplant. 2012 Jan;31(1):27-36. doi: 10.1016/j.healun.2011.10.012.

PMID:
22153550
20.

Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery.

DeRose JJ Jr, Umana JP, Argenziano M, Catanese KA, Gardocki MT, Flannery M, Levin HR, Sun BC, Rose EA, Oz MC.

J Am Coll Cardiol. 1997 Dec;30(7):1773-7.

Supplemental Content

Support Center